Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

NCT07637942 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

HIV -1 Infection

Interventions

DRUG: Every 4-week long-acting injectable cabotegravir and rilpivirine

Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Collaborators

[object Object]
[object Object]
[object Object]